- All sections
- A - Human necessities
- A01N - Preservation of bodies of humans or animals or plants or parts thereof biocides, e.g. as disinfectants, as pesticides or as herbicides pest repellants or attractantsplant growth regulators
- A01N 1/125 - Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
Patent holdings for IPC class A01N 1/125
Total number of patents in this class: 124
10-year publication summary
|
0
|
0
|
0
|
1
|
6
|
17
|
14
|
5
|
42
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The General Hospital Corporation | 4810 |
4 |
| Takeda Pharmaceutical Company Limited | 2728 |
4 |
| Osiris Therapeutics, Inc. | 103 |
4 |
| X-Therma Inc. | 42 |
4 |
| Flaskworks, LLC | 44 |
4 |
| Institute of Chemistry, Chinese Academy of Sciences | 237 |
3 |
| LifeNet Health | 279 |
3 |
| Meharry Medical College | 61 |
3 |
| Peking University Third Hospital | 50 |
3 |
| Iovance Biotherapeutics, Inc. | 364 |
3 |
| BMG Incorporated | 19 |
2 |
| Membrane Protective Technologies, Inc. | 24 |
2 |
| National University Corporation Kanazawa University | 250 |
2 |
| Regents of the University of Minnesota | 2773 |
2 |
| University Health Network | 1067 |
2 |
| University of Maryland, College Park | 1061 |
2 |
| Allogene Therapeutics, Inc. | 156 |
2 |
| Vivex Biologics Group, Inc. | 129 |
2 |
| Ossium Health, Inc. | 54 |
2 |
| Aspen Neuroscience, Inc. | 40 |
2 |
| Other owners | 69 |